Featured Stories
First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

FDA Warning About Surgical Tool That May Spread Cancer

On Monday, the Food and Drug Administration (FDA) updated an earlier safety alert to advise that the power morcellator should no longer be used in uterine surgeries for “the vast majority” of women because of the risk of spreading cancer.

The power morcellator cuts uterine tissue into small pieces that can be removed through tiny incisions made during minimally invasive surgery, and this makes it a popular tool for fibroid removal and some hysterectomies. But if a woman has an undetected cancer, the rapidly spinning blades can fling malignant cells around inside her abdomen, spreading the cancer, the New York Times reports. Though fibroids are benign, they can hide uterine sarcoma, an aggressive cancer that can be rapidly fatal once it spreads. Continue reading

Posted in Defective Medical Devices, Health Concerns |

Radiation from Cell Phones Linked to Brain Cancer, Study Suggests

Cell phone use is linked to a risk of brain cancer, a study published in the International Journal of Oncology suggests. Researchers analyzed the relationship between mobile phone use and glioma, a specific type of brain cancer that has a 0.005 percent chance of being diagnosed. The study found a 300 percent increased risk among participants who used cell phones for more than 25 years compared to those who used wireless phones for a year or less. A tripled rate of gliomas therefore correlates to 0.015 percent, or 15 out of 100,000 people being diagnosed, Business Tech reports.

The study found that the risk of brain cancer was 70 percent higher in people who used cell phones for more than a year compared to those used them for one year or less. The authors stated that the number of years of use is just as important as the number of hours of mobile phone use. A quarter of the participants spent 2,376 or more using their phones over their lifetime; this equates to roughly 40 minutes a day over ten years. Compared to people who never used cell phones or used them less than 39 hours in their lifetime, this group was associated with a 250 percent increased risk of brain tumors. Continue reading

Posted in Legal News |

Hookah Smoking May Increase Leukemia Risk

Researchers from San diegohave found that smoking hookah – a type of flavored tobacco – could lead to an increase in leukemia.

Hookah smoke doubles exposure to benzene, which the U.S. National Toxicology Program classifies as a Group 1 carcinogen, a substance that is proven to cause cancer in humans. The World Health Organization (WHO) says there is no safe level of exposure for the chemical. Continue reading

Posted in Health Concerns, Toxic Substances |

Health Canada Warns of Insulin Pump Tubing Detachment

Insulin pump infusion sets manufactured by Medtronic of Canada Inc., Roche Diagnostics, LifeScan Canada Inc, and Auto Control Medical Inc. have a risk of tubing detachment, according to a safety notification issued by Unomedical a/s in consultation with Health Canada. The alert, dated November 21st, warns that there have been growing reports of tubing become detached from the connect/disconnect location.

Insulin pumps deliver insulin to diabetic patients through a catheter. They can be programmed to administer small doses of insulin continuously or a larger dose close to mealtime to control blood sugar. Continue reading

Posted in Legal News |

Sun Pharmaceutical’s Effexor Recalled for the Second Time This Year

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor (venlafaxine), in the second recall of the drug this year, the Food and Drug Administration (FDA) said.

In both instances, the recalled drug was manufactured at the Indian generic drug maker’s plant in Halol in the state of Gujarat. The drugs were recalled after they failed to dissolve properly in quality tests, the Wall Street Journal reports. The earlier recall, in June, was for 252,000 bottles of Effexor. Continue reading

Posted in Defective Products, Pharmaceuticals, Product Recalls, Recalled Drugs |

Stelara Linked to Risk of Serious Skin Conditions

Stelara, a drug used to treat moderate to severe plaque psoriasis and active psoriatic arthritis, has been linked to a risk of severe skin conditions. According to a safety announcement issued on November 21st on Health Canada’s website, Stelara has been associated with cases of exfoliative dermatitis and erythrodermic psoriasis. These reactions, which occur within a few days of receiving the medication, can be severe and lead to hospitalization.

Stelara is manufactured by Janssen. The safety announcement states that the product monograph for Stelara will be updated to include the risk of these serious skin conditions. The letter, addressed to physicians, notes that the symptoms of exfoliative dermatitis and erythrodermic psoriasis may be the same. Healthcare professionals are advised to inform patients of these symptoms and report them. If a drug reaction is suspected, use of the drug should be discontinued. Continue reading

Posted in Legal News |

Patients with Knee Problems May Want to Reconsider before Undergoing Knee Replacement

Getting a total knee replacement may seem like an appealing option for someone suffering from sore and creaky knees, but these devices may not be as beneficial as one would hope, according to Well, the New York Times health blog. In 2012, more than 600,000 knee replacement surgeries were performed compared to about 250,000 just 15 years ago.

Manufacturers of knee replacements often claim that the devices have a wide variety of benefits, offering increased mobility, less pain and overall a more youthful lifestyle. However, a growing body of evidence shows that many patients should try other methods to improve their knees first. Research suggests that many people are undergoing the procedures prematurely and gaining limited benefit. Figures from the American Academy of Orthopaedic Surgeons shows that in between the ages of 45 and 64, the number of knee replacements increased drastically by 205 percent between 2000 and 2012. The increase was only 95 percent in people 65 and older. Continue reading

Posted in Legal News |

Energy Drinks Can be Deadly for Children

New research shows that children face serious and possibly deadly side effects from the consumption of energy drinks.

Between 2010 and 2013, poison control centers received more than 5,000 reports of people who got sick from energy drinks, NBC News reports. Many of the cases involved serious side effects, such as seizures, irregular heart rhythmor dangerously high blood pressure, the researchers told a meeting of the American Heart Association. Children under age 6 often consumed energy drinks without knowing what they were drinking. Dr. Steven Lipshultz, co-author of the study and head of pediatrics at the Children’s Hospital of Michigan, said, “They . . . found it in the refrigerator, or left by a parent or an older sibling.” Continue reading

Posted in Food Products, Health Concerns |

Regulators Review Death Risk Associated with Long-Term Use of Duel Antiplatelet Therapy

Preliminary data from a clinical trial has prompted safety regulators to review the safety of using duel antiplatelet therapy long-term. On Sunday, the U.S. Food and Drug Administration (FDA) issued a safety announcement stating that it was evaluating this data.

The data stemmed from The Dual Antiplatelet Therapy (DAPT) trial; findings were published in the New England Journal of Medicine on November 16th. Although the study found a decreased risk of heart attacks and clot formation in stents with 30 months of dual antiplatelet therapy, there was an overall higher risk of death compared to 12 months of treatment. Researchers looked at patients who underwent dual treatment with the aspirin plus either clopidogrel (Plavix) or prasugrel (Effient) after undergoing stent implantation. Stents are often used in patients with narrowed arteries; they are essentially tubes that are intended to maintain blood flow and keep the vessels open.

“We are communicating this safety information while we continue to evaluate the results from this trial and other available data. We will communicate our final conclusions and recommendations when our evaluation is complete.” the FDA stated. Continue reading

Posted in Legal News |

Johnson & Johnson to Pay More than $2.2 Billion in Civil and Criminal Settlements

Health care giant Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil cases arising from allegations relating to the drugs Risperdal (risperidone), Invega (paliperidone) and Natrecor (nesiritide). The allegations include promotion for uses not approved as safe and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to Omnicare Inc., the largest pharmacy provider to nursing homes.

The global resolution is one of the largest health care fraud settlements in U.S. history, with criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion, according to a news release from the Department of Justice. Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals |

© 2005-2014 Parker Waichman LLP ®. All Rights Reserved.